search again

Dolasetron, Oral

Nationwide rates for HCPCS Q0180

Dolasetron mesylate, 100 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 24-hour dosage regimen

Rates data updated July 2026.

Facilitymedian $83 · 10th–90th $59$1660%20%10th90th$83Professionalmedian $60 · 10th–90th $58$1020%50%10th90th$60$0.1$1.0$20.0$500.0$10.0K$200.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$57.54
Median
$79.43
Typical High
$162.18
Aetna
Setting
Professional
Modifier
Global
Typical Low
$57.54
Median
$60.26
Typical High
$63.10
BCBS
Setting
Facility
Modifier
Global
Typical Low
$64.57
Median
$91.20
Typical High
$165.96
BCBS
Setting
Professional
Modifier
Global
Typical Low
$57.54
Median
$72.44
Typical High
$138.04
Cigna
Setting
Facility
Modifier
Global
Typical Low
$64.57
Median
$102.33
Typical High
$295.12
Cigna
Setting
Professional
Modifier
Global
Typical Low
$61.66
Median
$61.66
Typical High
$104.71
United
Setting
Facility
Modifier
Global
Typical Low
$57.54
Median
$93.33
Typical High
$138.04
United
Setting
Professional
Modifier
Global
Typical Low
$60.26
Median
$60.26
Typical High
$104.71